STOCK TITAN

[Form 4] Argan, Inc Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Argan, Inc. (AGX) – Form 4 Insider Transaction Summary

Director Peter W. Getsinger reported three transactions involving the company’s common stock:

  • Sale: On 26 Jun 2025, he sold 3,456 shares in the open market at $212.01 per share, generating roughly $732.7 thousand in proceeds.
  • Gift to Donor-Advised Fund: On 30 Jun 2025, he transferred 1,000 shares at no consideration to a donor-advised fund managed by Martha’s Vineyard Investment Advisors.
  • Family Gift: On the same date, he gifted 999 shares (333 shares each) to his three children.

Following these transactions, Getsinger’s direct beneficial ownership declined from 18,351 to 12,896 shares, a 29.7 % reduction. No derivative securities were reported.

The filing does not indicate that the sale was executed under a Rule 10b5-1 trading plan. Investors often view sizeable insider sales—particularly absent a preset plan—as a potential negative sentiment signal, although philanthropic gifts may be neutral with respect to corporate outlook.

Argan, Inc. (AGX) – Riepilogo delle transazioni interne (Form 4)

Il direttore Peter W. Getsinger ha comunicato tre operazioni riguardanti le azioni ordinarie della società:

  • Vendita: Il 26 giugno 2025 ha venduto 3.456 azioni sul mercato aperto a 212,01 $ per azione, ottenendo un ricavo di circa 732,7 mila $.
  • Donazione a fondo consigliato dal donatore: Il 30 giugno 2025 ha trasferito 1.000 azioni senza alcun corrispettivo a un fondo gestito da Martha’s Vineyard Investment Advisors.
  • Regalo familiare: Nella stessa data, ha donato 999 azioni (333 azioni ciascuno) ai suoi tre figli.

Dopo queste operazioni, la posizione diretta di Getsinger è diminuita da 18.351 a 12.896 azioni, pari a una riduzione del 29,7%. Non sono stati segnalati titoli derivati.

La comunicazione non indica che la vendita sia stata effettuata nell'ambito di un piano di negoziazione Rule 10b5-1. Gli investitori spesso interpretano vendite significative da parte di insider — soprattutto in assenza di un piano prestabilito — come un possibile segnale negativo, anche se le donazioni filantropiche possono essere considerate neutre rispetto alle prospettive aziendali.

Argan, Inc. (AGX) – Resumen de transacciones internas (Formulario 4)

El director Peter W. Getsinger reportó tres operaciones relacionadas con las acciones comunes de la empresa:

  • Venta: El 26 de junio de 2025, vendió 3,456 acciones en el mercado abierto a $212.01 por acción, generando aproximadamente en ingresos.
  • Donación a fondo asesorado por donante: El 30 de junio de 2025 transfirió 1,000 acciones sin contraprestación a un fondo asesorado por donantes gestionado por Martha’s Vineyard Investment Advisors.
  • Regalo familiar: En la misma fecha, regaló 999 acciones (333 acciones para cada uno) a sus tres hijos.

Tras estas transacciones, la posesión directa de Getsinger disminuyó de 18,351 a 12,896 acciones, una reducción del 29.7%. No se reportaron valores derivados.

El reporte no indica que la venta se haya realizado bajo un plan de negociación Rule 10b5-1. Los inversores suelen interpretar ventas significativas de insiders — especialmente sin un plan preestablecido — como una posible señal negativa, aunque las donaciones filantrópicas pueden considerarse neutrales respecto a las perspectivas corporativas.

Argan, Inc. (AGX) – 내부자 거래 보고서(Form 4) 요약

이사 Peter W. Getsinger가 회사 보통주와 관련된 세 건의 거래를 보고했습니다:

  • 매도: 2025년 6월 26일, 그는 3,456주를 주당 $212.01에 공개 시장에서 매도하여 약 $732,700의 수익을 올렸습니다.
  • 기부자 자문 기금에 기증: 2025년 6월 30일, 그는 Martha’s Vineyard Investment Advisors가 관리하는 기부자 자문 기금에 1,000주를 대가 없이 이전했습니다.
  • 가족 선물: 같은 날, 세 자녀에게 각각 333주씩 총 999주를 증여했습니다.

이 거래들 후 Getsinger의 직접 소유 주식은 18,351주에서 12,896주로 감소하여 29.7% 줄었습니다. 파생 증권은 보고되지 않았습니다.

해당 신고서에는 이 매도가 Rule 10b5-1 거래 계획에 따라 이루어졌다는 내용이 없습니다. 투자자들은 사전에 정해진 계획 없이 대규모 내부자 매도를 종종 부정적인 신호로 해석하지만, 자선 기부는 기업 전망과는 무관할 수 있습니다.

Argan, Inc. (AGX) – Résumé des transactions d’initiés (Formulaire 4)

Le directeur Peter W. Getsinger a déclaré trois transactions concernant les actions ordinaires de la société :

  • Vente : Le 26 juin 2025, il a vendu 3 456 actions sur le marché ouvert au prix de 212,01 $ par action, générant environ 732,7 mille $ de produit.
  • Don à un fonds conseillé par le donateur : Le 30 juin 2025, il a transféré 1 000 actions sans contrepartie à un fonds conseillé par le donateur géré par Martha’s Vineyard Investment Advisors.
  • Don familial : Le même jour, il a offert 999 actions (333 actions chacune) à ses trois enfants.

Suite à ces opérations, la possession directe de Getsinger a diminué de 18 351 à 12 896 actions, soit une réduction de 29,7 %. Aucun titre dérivé n’a été déclaré.

Le dépôt ne précise pas que la vente ait été réalisée dans le cadre d’un plan de négociation Rule 10b5-1. Les investisseurs considèrent souvent les ventes importantes d’initiés — surtout en l’absence d’un plan prédéfini — comme un signal potentiellement négatif, bien que les dons philanthropiques puissent être neutres en ce qui concerne les perspectives de l’entreprise.

Argan, Inc. (AGX) – Zusammenfassung der Insider-Transaktionen (Formular 4)

Der Direktor Peter W. Getsinger meldete drei Transaktionen mit den Stammaktien des Unternehmens:

  • Verkauf: Am 26. Juni 2025 verkaufte er 3.456 Aktien am offenen Markt zu je 212,01 $ und erzielte damit rund 732,7 Tausend $ Erlös.
  • Schenkung an einen Donor-Advised Fund: Am 30. Juni 2025 übertrug er 1.000 Aktien unentgeltlich an einen von Martha’s Vineyard Investment Advisors verwalteten Spendenfonds.
  • Familienschenkung: Am selben Tag schenkte er seinen drei Kindern jeweils 333 Aktien, insgesamt 999 Aktien.

Nach diesen Transaktionen verringerte sich Getsingers direkter Besitz von 18.351 auf 12.896 Aktien, was einer Reduzierung um 29,7 % entspricht. Keine derivativen Wertpapiere wurden gemeldet.

Die Meldung weist nicht darauf hin, dass der Verkauf im Rahmen eines Rule 10b5-1 Handelsplans erfolgte. Investoren sehen größere Insider-Verkäufe – insbesondere ohne vorab festgelegten Plan – oft als potenzielles negatives Signal, obwohl philanthropische Schenkungen hinsichtlich der Unternehmensperspektive neutral bewertet werden können.

Positive
  • None.
Negative
  • None.

Insights

TL;DR – Director sold ~$733k of AGX, cutting stake by ~30 %; modest negative signal.

Getsinger’s open-market disposal of 3,456 shares at $212.01 equates to about one-fifth of his pre-sale holdings, and total dispositions (including gifts) reduce ownership by nearly a third. While a single Form 4 rarely alters fundamentals, insider sales outside a 10b5-1 plan can suggest lowered personal conviction or liquidity needs. The remaining 12,896-share stake still aligns him with shareholders, but the magnitude and timing deserve monitoring, especially if additional sales follow. Because the gifts were non-cash transfers, they do not convey valuation sentiment but further reduce alignment. Overall impact: slightly negative.

Argan, Inc. (AGX) – Riepilogo delle transazioni interne (Form 4)

Il direttore Peter W. Getsinger ha comunicato tre operazioni riguardanti le azioni ordinarie della società:

  • Vendita: Il 26 giugno 2025 ha venduto 3.456 azioni sul mercato aperto a 212,01 $ per azione, ottenendo un ricavo di circa 732,7 mila $.
  • Donazione a fondo consigliato dal donatore: Il 30 giugno 2025 ha trasferito 1.000 azioni senza alcun corrispettivo a un fondo gestito da Martha’s Vineyard Investment Advisors.
  • Regalo familiare: Nella stessa data, ha donato 999 azioni (333 azioni ciascuno) ai suoi tre figli.

Dopo queste operazioni, la posizione diretta di Getsinger è diminuita da 18.351 a 12.896 azioni, pari a una riduzione del 29,7%. Non sono stati segnalati titoli derivati.

La comunicazione non indica che la vendita sia stata effettuata nell'ambito di un piano di negoziazione Rule 10b5-1. Gli investitori spesso interpretano vendite significative da parte di insider — soprattutto in assenza di un piano prestabilito — come un possibile segnale negativo, anche se le donazioni filantropiche possono essere considerate neutre rispetto alle prospettive aziendali.

Argan, Inc. (AGX) – Resumen de transacciones internas (Formulario 4)

El director Peter W. Getsinger reportó tres operaciones relacionadas con las acciones comunes de la empresa:

  • Venta: El 26 de junio de 2025, vendió 3,456 acciones en el mercado abierto a $212.01 por acción, generando aproximadamente en ingresos.
  • Donación a fondo asesorado por donante: El 30 de junio de 2025 transfirió 1,000 acciones sin contraprestación a un fondo asesorado por donantes gestionado por Martha’s Vineyard Investment Advisors.
  • Regalo familiar: En la misma fecha, regaló 999 acciones (333 acciones para cada uno) a sus tres hijos.

Tras estas transacciones, la posesión directa de Getsinger disminuyó de 18,351 a 12,896 acciones, una reducción del 29.7%. No se reportaron valores derivados.

El reporte no indica que la venta se haya realizado bajo un plan de negociación Rule 10b5-1. Los inversores suelen interpretar ventas significativas de insiders — especialmente sin un plan preestablecido — como una posible señal negativa, aunque las donaciones filantrópicas pueden considerarse neutrales respecto a las perspectivas corporativas.

Argan, Inc. (AGX) – 내부자 거래 보고서(Form 4) 요약

이사 Peter W. Getsinger가 회사 보통주와 관련된 세 건의 거래를 보고했습니다:

  • 매도: 2025년 6월 26일, 그는 3,456주를 주당 $212.01에 공개 시장에서 매도하여 약 $732,700의 수익을 올렸습니다.
  • 기부자 자문 기금에 기증: 2025년 6월 30일, 그는 Martha’s Vineyard Investment Advisors가 관리하는 기부자 자문 기금에 1,000주를 대가 없이 이전했습니다.
  • 가족 선물: 같은 날, 세 자녀에게 각각 333주씩 총 999주를 증여했습니다.

이 거래들 후 Getsinger의 직접 소유 주식은 18,351주에서 12,896주로 감소하여 29.7% 줄었습니다. 파생 증권은 보고되지 않았습니다.

해당 신고서에는 이 매도가 Rule 10b5-1 거래 계획에 따라 이루어졌다는 내용이 없습니다. 투자자들은 사전에 정해진 계획 없이 대규모 내부자 매도를 종종 부정적인 신호로 해석하지만, 자선 기부는 기업 전망과는 무관할 수 있습니다.

Argan, Inc. (AGX) – Résumé des transactions d’initiés (Formulaire 4)

Le directeur Peter W. Getsinger a déclaré trois transactions concernant les actions ordinaires de la société :

  • Vente : Le 26 juin 2025, il a vendu 3 456 actions sur le marché ouvert au prix de 212,01 $ par action, générant environ 732,7 mille $ de produit.
  • Don à un fonds conseillé par le donateur : Le 30 juin 2025, il a transféré 1 000 actions sans contrepartie à un fonds conseillé par le donateur géré par Martha’s Vineyard Investment Advisors.
  • Don familial : Le même jour, il a offert 999 actions (333 actions chacune) à ses trois enfants.

Suite à ces opérations, la possession directe de Getsinger a diminué de 18 351 à 12 896 actions, soit une réduction de 29,7 %. Aucun titre dérivé n’a été déclaré.

Le dépôt ne précise pas que la vente ait été réalisée dans le cadre d’un plan de négociation Rule 10b5-1. Les investisseurs considèrent souvent les ventes importantes d’initiés — surtout en l’absence d’un plan prédéfini — comme un signal potentiellement négatif, bien que les dons philanthropiques puissent être neutres en ce qui concerne les perspectives de l’entreprise.

Argan, Inc. (AGX) – Zusammenfassung der Insider-Transaktionen (Formular 4)

Der Direktor Peter W. Getsinger meldete drei Transaktionen mit den Stammaktien des Unternehmens:

  • Verkauf: Am 26. Juni 2025 verkaufte er 3.456 Aktien am offenen Markt zu je 212,01 $ und erzielte damit rund 732,7 Tausend $ Erlös.
  • Schenkung an einen Donor-Advised Fund: Am 30. Juni 2025 übertrug er 1.000 Aktien unentgeltlich an einen von Martha’s Vineyard Investment Advisors verwalteten Spendenfonds.
  • Familienschenkung: Am selben Tag schenkte er seinen drei Kindern jeweils 333 Aktien, insgesamt 999 Aktien.

Nach diesen Transaktionen verringerte sich Getsingers direkter Besitz von 18.351 auf 12.896 Aktien, was einer Reduzierung um 29,7 % entspricht. Keine derivativen Wertpapiere wurden gemeldet.

Die Meldung weist nicht darauf hin, dass der Verkauf im Rahmen eines Rule 10b5-1 Handelsplans erfolgte. Investoren sehen größere Insider-Verkäufe – insbesondere ohne vorab festgelegten Plan – oft als potenzielles negatives Signal, obwohl philanthropische Schenkungen hinsichtlich der Unternehmensperspektive neutral bewertet werden können.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Getsinger Peter W

(Last) (First) (Middle)
35 SNOWS POINT

(Street)
EDGARTOWN MA 02539

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/26/2025 S 3,456(1) D $212.01 14,895 D
Common Stock 06/30/2025 G 1,000(2) D $0 13,895 D
Common Stock 06/30/2025 G 999(3) D $0 12,896 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On June 26, 2025, the Reporting Person sold 3,456 shares of the Issuer's common stock on the open market at a price of $212.01 per share.
2. On June 30, 2025, the Reporting Person transferred 1,00 shares of the Issuer's common stock to a donor advised fund managed by Martha's Vineyard Investment Advisors.
3. On June 30, 2025, the Reporting Person gifted 333 shares to each of his three children.
/s/ Peter W. Getsinger 06/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AGX shares did Director Peter W. Getsinger sell?

He sold 3,456 shares on 26 Jun 2025.

At what price were the AGX shares sold?

The shares were sold at $212.01 per share.

What is the director’s remaining AGX ownership after the transactions?

Getsinger now directly owns 12,896 shares of Argan, Inc.

Were any shares donated or gifted in this Form 4?

Yes, 1,000 shares were donated to a donor-advised fund and 999 shares were gifted to his three children.

Was the sale executed under a Rule 10b5-1 trading plan?

The filing does not indicate that the transaction was conducted under a Rule 10b5-1 plan.
Argan Inc

NYSE:AGX

AGX Rankings

AGX Latest News

AGX Latest SEC Filings

AGX Stock Data

2.85B
13.08M
7.02%
89.4%
4.4%
Engineering & Construction
Construction - Special Trade Contractors
Link
United States
ARLINGTON